Hypertension,Essential

10

Review clinical trials related to Hypertension,Essential. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Optical Coherence Tomography Angiography in Subjects With Retinal Vascular Disease

This study will perform a prospective, longitudinal analysis of clinical and imaging findings from normal controls and subjects with retinal vascular disease to better define the diagnostic imaging criteria that signify change in disease stage. This includes disease progression in early stages of disease or disease regression with appropriate standard-of-care treatment.

Participants needed: 1,050
Trial details
Age: 18-99Biological sex: AllType: InterventionalSponsor: Johns Hopkins UniversityUpdated: Jun 17, 2026Locations: 1
Eligibility criteria

Children (age<18) [+14]

Status: Recruiting

Mobile Health Program for Rural Hypertension

Hypertension (HTN) is the leading modifiable cause of cardiovascular disease. Rural individuals experience challenges of the rural health divide: geographic distance from providers, social isolation, limited social resources, and high rates of low health literacy. This study evaluates a home-based blood pressure monitoring (HBPM) program that provides longitudinal health education, empathic guidance, monitoring, and adaptable patient-centered coaching to rural individuals. Participants in this study will be randomized to receive (1) HBPM with the intervention; or (2) the control, consisting of HBPM and a smartphone with a general health application (WebMD).

Participants needed: 334
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: University of PittsburghUpdated: Nov 19, 2025Locations: 1
Eligibility criteria

History of uncontrolled hypertension, identified from the electronic health reco... [+3]

Heart failure necessitating hospital admission ≤3 months prior to study inclusio... [+7]

Status: Recruiting

The Benefits of Natural Medicine, Vitamin IV Therapy and Supplements: Maintaining Good Health Through Nature

Herbal Medicine is known as the medicinal use of herbal substances as a means of treating different conditions in the human body to ensure that the body remains in optimal health and wellness. These substances are known to contain very active ingredients in it and as such is also a very potent means of managing diseases and ailments in the body. Herbal medicine has always been a standby source of getting relief from various conditions over centuries, however, it can be categorically said that the mode of usage of these herbal substances has changed over time. Traditional healers help individuals to make meaning out of the natural herbs seen around that can be useful to one's health. Herbal medicine is the use of plants to treat disease and enhance general health and wellbeing. Herbs can interact with other pharmaceutical medications and should be taken with care. Always seek a regular medical doctor (GP) about any health concerns and tell them about any herbal medicines you are taking or thinking of taking. Never stop taking prescribed medications in favor of herbs without first discussing it with your GP.

Participants needed: 25
Trial details
Age: 21-80Biological sex: AllType: ObservationalSponsor: Faith A. RichardsonUpdated: Sep 23, 2025Locations: 1Duration: 1 Week
Eligibility criteria

N/A

N/A

Status: Recruiting

An OS to Evaluate Effectiveness and Safety of Fixed-dose Combinations of FMS/AML or FMS/AML/HCTZ

The main purpose of this observation study is to collect data on the effects and side effects for 12 weeks of the medication administration of the single-pill combinations, which are fimasartan/amlodipine or fimasartan/amlodipine/hydrochlorothiazide, based on fimasartan. (Stage 1). Also, this study will evaluate major cardiovascular events, long-term blood pressure control, and the safety by follow-up of those who consent to the extended study for about 2 years (96 weeks).(Stage 2)

Participants needed: 20,000
Trial details
Age: 19+Biological sex: AllType: ObservationalSponsor: Boryung Pharmaceutical Co., LtdUpdated: Sep 12, 2025Locations: 1
Eligibility criteria

Patients who voluntarily consent on the informed consent form and understand the... [+6]

The patients who are suspected of having secondary hypertension or confirmed to... [+3]

Status: Recruiting

Improving Hypertension Control in CHina and ARGEntina With a Mobile APP-based Telecare System

The CHARGE-APP project will investigate whether an innovative management strategy of hypertension based on the combination of usual care visits and ESH CARE App compared to standard care, is associated with differences in outcome, including control rate of office, home and ambulatory BP, cardiovascular and renal intermediate end points at one year, and changes in a number of blood pressure-related variables throughout the study.

Participants needed: 480
Trial details
Age: 18-80Biological sex: AllType: InterventionalSponsor: Istituto Auxologico ItalianoUpdated: Feb 27, 2025Locations: 8
Eligibility criteria

Male and female subjects; [+3]

eGFR <45 mL/min/1.73 m2 (CKD-EPI creatinine equation 2009); [+15]

Status: Recruiting

A Study to Evaluate the Efficacy and Safety of AD-224

The purpose of this study is to evaluate the efficacy and safety of AD-224

Participants needed: 252
Trial details
Phase: Phase 3Age: 19+Biological sex: AllType: InterventionalSponsor: Addpharma Inc.Updated: Feb 4, 2025Locations: 1
Eligibility criteria

Signed informed consent [+2]

Patient with Secondary Hypertension [+1]

Status: Recruiting

Efficacy of Songling Xuemaikang Capsules on Grade 1 Hypertension: a Randomized Controlled Trial

The purpose of this study is: 1. To evaluate the efficacy of Songling Xuemaikang Capsules(SLXMKC) with grade 1 hypertension. 2. To reveal the potiential effects of SLXMKC on vascular function and structure of patients with grade 1 hypertension. 3. To explore the underlying mechanisms of the therapeutic effects of SLXMKC on the intervention of grade 1 hypertension.

Participants needed: 100
Trial details
Phase: Phase 4Age: 35-65Biological sex: AllType: InterventionalSponsor: Xiyuan Hospital of China Academy of Chinese Medical SciencesUpdated: Aug 20, 2024Locations: 5
Eligibility criteria

Age between 35-65 years old, male or female; [+3]

Significant liver and kidney dysfunction, ALT and AST upper the twice of normal... [+8]

Status: Not yet recruiting

Treatment and Handling Severe Obesity-Related Comorbidities in Adolescents Through Exercise

The main objective of this project is to analyze the effect of a tailor-made, one-to-one, exercise program (aiming to treat and handle obesity-related comorbidities in adolescents with severe obesity at high risk of cardiovascular disease development) on BMI z-score, specific comorbidities, and other health-related indicators. This project will further allow to analyze the long-term impact of the exercise program not only on clinical parameters, but also on the interaction with drug-treatment, health-related behaviors, and quality of life, further contributing to the understanding of the individual characteristics associated with a positive exercise response and frequency. The secondary objective of the THOR-X project is to build an educational toolkit, based on project results and relevant literature, addressed to health and exercise professionals, in order to improve management of adolescents with obesity, in particular those with severe obesity.

Participants needed: 24
Trial details
Age: 13-18Biological sex: AllType: InterventionalSponsor: University of LisbonUpdated: Jul 29, 2024
Eligibility criteria

adolescents aged 13 to 18 years; [+6]

major or unstable clinical conditions (other than obesity or its related comorbi... [+5]

Status: Not yet recruiting

Endothelial Function in Prehypertension

In the frame of this proposal investigators will test the hypothesis that high normal blood pressure (prehypertension; PreHT) induces systemic endothelial dysfunction and endothelial activation in both micro- and macrocirculation, reduces re-endothelialization potential of human endothelial progenitor cells (EPCs) and increases the level of endothelial extracellular vesicles (EVs), which are accompanied by increased oxidative stress level. Furthermore, initial vascular and left ventricle (LV) remodeling contributes to changes in systemic hemodynamics and may be influenced by altered regulatory role of renin-angiotensin system (RAS) and autonomic nervous system (ANS) in PreHT but otherwise healthy individuals. To distinguish high normal blood pressure effect from those considered normal or high, study will be performed in three groups of individuals: prehypertensive (BP 130-139/85-89 mmHg), hypertensive (stage I, BP 140-150/90-100 mmHg), and controls (BP less than or equal to 129/85 mmHg). Altogether, the impairment of normal vascular relaxation mechanisms, endothelial activation as well as vascular and LV remodeling could play crucial role in increased cardiovascular risk and CVDs incidence in PreHT individuals. Moreover, the prognostic significance of assessing endotehlial dysfunction in hypertension (as well as in PreHT) is yet to be established.

Participants needed: 90
Trial details
Age: 18-69Biological sex: AllType: ObservationalSponsor: Josip Juraj Strossmayer University of OsijekUpdated: Mar 18, 2024Locations: 1
Eligibility criteria

adults of both sexes with normotensive, prehypertensive and grade I hypertension...

cardiovascular diseases, but grade I hypertension (BP 140-150/90-100 mmHg) [+5]

Status: Recruiting

Blood Pressure Reduction in Patients With Asymptomatic Aortic VALVE Stenosis

The aim of this study is to investigate the effect of strict blood pressure control versus conventional care in patients with asymptomatic moderate to severe aortic valve stenosis. The study is a randomized (1:1), open label, controlled intervention trial. Hypothesis: 1. Strict BP control for 12 months reduces the progression of LV remodelling compared to conventional treatment. 2. Strict BP control for 2 years reduces the increase in aortic valve calcification and LV remodelling compared to conventional treatment. 3. Strict BP reduction for up to 10 years reduces the need for aortic valve replacement and cardiovascular events compared to conventional care.

Participants needed: 200
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Henrik WiggersUpdated: Nov 3, 2020Locations: 6
Eligibility criteria

Aortic valve peak velocity (Vmax) of 3.0-5.0 m/s and/or aortic valve area (AVA)... [+6]

Symptoms due to AS [+8]